TrialPanorama/TrialPanorama-database huggingface dataset:
Study 18279048 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 15841403 — Predictive Biomarker (PRD): SLA mRNA
Genes: SLA; SLAP; SLAP1
Study 19684411 — Surrogate Endpoint (SUR): Serum creatinine
Study 17335562 — Monitoring Biomarker (MOI): Procalcitonin
Study 17335562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29562260 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study 28252533 — Safety Biomarker (SAF): Derived neutrophil to lymphocyte
Study 28252533 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 28252533 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 25466953 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 25466953 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 18308793 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 31343447 — Safety Biomarker (SAF): Hyaluronic acid
Study 9718869 — Predictive Biomarker (PRD): RTEL1 mRNA
Genes: RTEL1; C20orf41; KIAA1088; NHL
Study 24251360 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 24251360 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study 30142767 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 8797643 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 29021322 — Surrogate Endpoint (SUR): Blood pressure
Study 20185009 — Surrogate Endpoint (SUR): Blood pressure
Study 12133866 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 12133866 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 8958718 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 8958718 — Surrogate Endpoint (SUR): Blood pressure
Study 2938871 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 11859853 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 11859853 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 2144919 — Surrogate Endpoint (SUR): Blood pressure
Study 26117402 — Predictive Biomarker (PRD): APOA5 mRNA
Genes: APOA5; RAP3; UNQ411/PRO773
Study 22088414 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7821197 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 7821197 — Predictive Biomarker (PRD): ADA2 mRNA
Genes: ADA2; ADGF; CECR1; IDGFL
Study 2900816 — Surrogate Endpoint (SUR): Blood pressure
Study 26408621 — Surrogate Endpoint (SUR): Blood pressure
Study 24461666 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 1611979 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study 1611979 — Surrogate Endpoint (SUR): Blood pressure
Study 30456964 — Surrogate Endpoint (SUR): Blood pressure
Study 19713225 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19713225 — Surrogate Endpoint (SUR): Blood pressure
Study 12920494 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 27993631 — Monitoring Biomarker (MOI): Procalcitonin
Study 27993631 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22039668 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 22039668 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 7963155 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 2953691 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 2953691 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 31748705 — Surrogate Endpoint (SUR): Blood pressure
Study 31748705 — Surrogate Endpoint (SUR): Serum potassium
Study 29275402 — Surrogate Endpoint (SUR): Blood pressure
Study 18504547 — Predictive Biomarker (PRD): ADIPOQ mRNA
Genes: ADIPOQ; ACDC; ACRP30; APM1; GBP28
Study 11063191 — Surrogate Endpoint (SUR): Blood pressure
Study 30217232 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30217232 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18613251 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 1364197 — Surrogate Endpoint (SUR): Blood pressure
Study 23130748 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 23130748 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 21574710 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 23208128 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 23208128 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 8630312 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 8630312 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 8630312 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 1910103 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 27930447 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 12149201 — Predictive Biomarker (PRD): COL3A1 mRNA
Genes: COL3A1
Study 8729674 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 8729674 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 14618093 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 14618093 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 10868622 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study 16447879 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 16447879 — Safety Biomarker (SAF): Hyaluronic acid
Study 23969334 — Surrogate Endpoint (SUR): Probing pocket depth
Study 28089729 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 28089729 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 24260194 — Surrogate Endpoint (SUR): Blood pressure
Study 8252937 — Surrogate Endpoint (SUR): Blood pressure
Study 26538631 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 22959497 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 10533157 — Surrogate Endpoint (SUR): Bone mineral density
Study 24499951 — Surrogate Endpoint (SUR): Serum creatinine
Study 24499951 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 20673554 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study 20673554 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 29212716 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25851629 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15238183 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 15238183 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 15238183 — Surrogate Endpoint (SUR): Blood pressure
Study 11386854 — Predictive Biomarker (PRD): TPH1 mRNA
Genes: TPH1; TPH; TPRH; TRPH
Study 11386854 — Safety Biomarker (SAF): MTHFR
Study 9219480 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26476074 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 10955373 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10955373 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8808221 — Surrogate Endpoint (SUR): Bone mineral density
Study 8808221 — Surrogate Endpoint (SUR): Serum calcium
Study 26683683 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 25054594 — Predictive Biomarker (PRD): WIPF1 mRNA
Genes: WIPF1; WASPIP; WIP
Study 22209391 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 21942708 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 21942708 — Predictive Biomarker (PRD): SERPINA6 mRNA
Genes: SERPINA6; CBG
Study 21942708 — Predictive Biomarker (PRD): SERPINA7 mRNA
Genes: SERPINA7; TBG
Study 21942708 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 19220089 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 2406538 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 2406538 — Surrogate Endpoint (SUR): Blood pressure
Study 6111083 — Surrogate Endpoint (SUR): Blood pressure
Study 31228782 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31228782 — Surrogate Endpoint (SUR): Blood pressure
Study 28587952 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 28587952 — Surrogate Endpoint (SUR): Serum creatinine
Study 24142687 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 17309946 — Surrogate Endpoint (SUR): Blood pressure
Study 26654517 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26654517 — Surrogate Endpoint (SUR): Blood pressure
Study 11390337 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24092547 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study 24092547 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 24092547 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 24092547 — Predictive Biomarker (PRD): TXN mRNA
Genes: TXN; TRDX; TRX; TRX1
Study 24092547 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 18226326 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 27544742 — Surrogate Endpoint (SUR): Blood pressure
Study 27544742 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28842953 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 15598773 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 11719733 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 26744983 — Predictive Biomarker (PRD): SSB mRNA
Genes: SSB
Study 18024525 — Predictive Biomarker (PRD): HSPB1 mRNA
Genes: HSPB1; HSP27; HSP28
Study 9107182 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30913162 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 22665534 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 20502877 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 16130870 — Predictive Biomarker (PRD): TYR mRNA
Genes: TYR
Study 2682348 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study 10457878 — Surrogate Endpoint (SUR): Blood pressure
Study 7788574 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23190512 — Surrogate Endpoint (SUR): Serum creatinine
Study 30242948 — Surrogate Endpoint (SUR): Blood pressure
Study 30242948 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 21315807 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 12374709 — Surrogate Endpoint (SUR): Blood pressure
Study 29959787 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29959787 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26378033 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study 26378033 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 18723851 — Surrogate Endpoint (SUR): Blood pressure
Study 25012565 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 20856184 — Surrogate Endpoint (SUR): Blood pressure
Study 11809349 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 1326708 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 1326708 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1326708 — Surrogate Endpoint (SUR): Serum triglycerides
Study 21252702 — Surrogate Endpoint (SUR): Blood pressure
Study 18288974 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10953973 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 3286363 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 2921098 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2921098 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 28348100 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 28348100 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 7888741 — Surrogate Endpoint (SUR): Blood pressure
Study 31309975 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 12487386 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 184978 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 10704630 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 9344296 — Surrogate Endpoint (SUR): Bone mineral density
Study 22300506 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 22300506 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22300506 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 17070997 — Predictive Biomarker (PRD): ANXA3 mRNA
Genes: ANXA3; ANX3
Study 17070997 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SOD2 mRNA
Genes: SOD2
Study 17070997 — Predictive Biomarker (PRD): SOCS3 mRNA
Genes: SOCS3; CIS3; SSI3
Study 17070997 — Predictive Biomarker (PRD): IL1RN mRNA
Genes: IL1RN; IL1F3; IL1RA
Study 17070997 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 17070997 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 15598978 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 19174069 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19174069 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 19174069 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16306030 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26348767 — Surrogate Endpoint (SUR): Blood pressure
Study 19732408 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28632742 — Surrogate Endpoint (SUR): Serum uric acid
Study 31925817 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study 9438894 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 9438894 — Surrogate Endpoint (SUR): Blood pressure
Study 24695986 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 24695986 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 8696988 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study 8696988 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 8696988 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 30201679 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 21935656 — Surrogate Endpoint (SUR): Blood pressure
Study 12219472 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 9926184 — Surrogate Endpoint (SUR): Blood pressure
Study 28743341 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25494869 — Surrogate Endpoint (SUR): Serum testosterone
Study 16424422 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10608768 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 17566894 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15763454 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 2355819 — Surrogate Endpoint (SUR): Blood pressure
Study 11514824 — Surrogate Endpoint (SUR): Blood pressure
Study 27440869 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 27440869 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8564635 — Surrogate Endpoint (SUR): Blood pressure
Study 31179798 — Surrogate Endpoint (SUR): Bone mineral density
Study 25012275 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 25012275 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25012275 — Surrogate Endpoint (SUR): Blood pressure
Study 11896130 — Surrogate Endpoint (SUR): Blood pressure
Study 7598054 — Predictive Biomarker (PRD): RTN1 mRNA
Genes: RTN1; NSP
Study 26323451 — Surrogate Endpoint (SUR): Probing pocket depth
Study 22091563 — Surrogate Endpoint (SUR): Bone mineral density
Study 10952368 — Surrogate Endpoint (SUR): Forced vital capacity
Study 28414090 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28414090 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 28414090 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study 28414090 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 26687425 — Predictive Biomarker (PRD): TNFRSF1A mRNA
Genes: TNFRSF1A; TNFAR; TNFR1
Study 26687425 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 29659879 — Predictive Biomarker (PRD): GPIHBP1 mRNA
Genes: GPIHBP1; HBP1
Study 29659879 — Surrogate Endpoint (SUR): Serum triglycerides
Study 9951781 — Surrogate Endpoint (SUR): Bone mineral density
Study 380318 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30623420 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 29947083 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 29947083 — Predictive Biomarker (PRD): PHEX mRNA
Genes: PHEX; PEX
Study 29947083 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 29947083 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 22815387 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7488768 — Predictive Biomarker (PRD): MFSD11 mRNA
Genes: MFSD11; ET
Study 7488768 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study 30832230 — Pharmacodynamic Biomarker (PDY): Insulin receptor substrate 1
Genes: IRS1
Study 30899946 — Surrogate Endpoint (SUR): Probing pocket depth
Study 17623113 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 16275936 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 10418541 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 2268864 — Surrogate Endpoint (SUR): Blood pressure
Study 30192018 — Safety Biomarker (SAF): DRD2
Study 19464164 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 17594986 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 9628295 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 27901255 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 10319666 — Surrogate Endpoint (SUR): Blood pressure
Study 10319666 — Surrogate Endpoint (SUR): Forced vital capacity
Study 26399940 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 12753943 — Surrogate Endpoint (SUR): Blood pressure
Study 8572841 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1741552 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 1741552 — Predictive Biomarker (PRD): UCN3 mRNA
Genes: UCN3; SPC
Study 26604728 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 12859446 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 12859446 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 9186459 — Surrogate Endpoint (SUR): Serum calcium
Study 9186459 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 29738282 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29738282 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 27091542 — Surrogate Endpoint (SUR): Blood pressure
Study 22293631 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 17235043 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 8157852 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 3149935 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 18327721 — Predictive Biomarker (PRD): NELFE mRNA
Genes: NELFE; RD; RDBP
Study 10487668 — Surrogate Endpoint (SUR): Bone mineral density
Study 29908220 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study 22251528 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 10761530 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 23059577 — Predictive Biomarker (PRD): CPB1 mRNA
Genes: CPB1; CPB; PCPB
Study 19888978 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study 19888978 — Predictive Biomarker (PRD): CDKN1B mRNA
Genes: CDKN1B; KIP1; p27
Study 16202731 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 16202731 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 27930762 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 27930762 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 26446978 — Surrogate Endpoint (SUR): Blood pressure
Study 25123549 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7516014 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7516014 — Surrogate Endpoint (SUR): Blood pressure
Study 31184266 — Surrogate Endpoint (SUR): Blood pressure
Study 25919976 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19329178 — Surrogate Endpoint (SUR): Blood pressure
Study 15383481 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study 7760966 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 452619 — Surrogate Endpoint (SUR): Blood pressure
Study 31551222 — Monitoring Biomarker (MOI): Procalcitonin
Study 31551222 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1